NASDAQ:HOLX - Hologic Stock Price, Forecast & News

Hologic trades on the NASDAQ under the ticker symbol "HOLX."

Hologic, Inc. (NASDAQ:HOLX) released its quarterly earnings results on Wednesday, November, 6th. The medical equipment provider reported $0.65 earnings per share (EPS) for the quarter, hitting the Zacks' consensus estimate of $0.65. The medical equipment provider had revenue of $865.80 million for the quarter, compared to analyst estimates of $846.54 million. Hologic had a positive return on equity of 29.67% and a negative net margin of 1.19%. The business's revenue was up 6.4% on a year-over-year basis. During the same quarter last year, the company posted $0.58 earnings per share. View Hologic's Earnings History.

Hologic is scheduled to release their next quarterly earnings announcement on Wednesday, January 29th 2020. View Earnings Estimates for Hologic.

Hologic will be holding an earnings conference call on Wednesday, January 29th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Hologic issued an update on its FY19 earnings guidance on Wednesday, November, 6th. The company provided earnings per share guidance of $2.60-2.65 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.44. The company issued revenue guidance of $3.4-3.5 billion, compared to the consensus revenue estimate of $3.35 billion.

13 equities research analysts have issued 12-month price targets for Hologic's stock. Their forecasts range from $50.00 to $62.00. On average, they anticipate Hologic's stock price to reach $55.50 in the next year. This suggests a possible upside of 2.2% from the stock's current price. View Analyst Price Targets for Hologic.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hologic in the last year. There are currently 1 sell rating, 5 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Hologic.

Headlines about HOLX stock have been trending somewhat negative this week, InfoTrie reports. The research group identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Hologic earned a media sentiment score of -1.7 on InfoTrie's scale. They also assigned news stories about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for Hologic.

Hologic saw a decrease in short interest during the month of December. As of December 31st, there was short interest totalling 4,380,000 shares, a decrease of 21.5% from the December 15th total of 5,580,000 shares. Based on an average daily trading volume, of 2,190,000 shares, the days-to-cover ratio is currently 2.0 days. Approximately 1.7% of the company's shares are sold short. View Hologic's Current Options Chain.

Some companies that are related to Hologic include Medtronic (MDT), Abbott Laboratories (ABT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), Teleflex (TFX), Varian Medical Systems (VAR), Steris (STE) and Insulet (PODD).

Based on aggregate information from My MarketBeat watchlists, some companies that other Hologic investors own include NVIDIA (NVDA), AbbVie (ABBV), Starbucks (SBUX), Alibaba Group (BABA), Bank of America (BAC), salesforce.com (CRM), AT&T (T), Home Depot (HD), Johnson & Johnson (JNJ) and Micron Technology (MU).

Hologic's stock is owned by a number of of retail and institutional investors. Top institutional investors include Wedge Capital Management L L P NC (0.29%), Assenagon Asset Management S.A. (0.29%), Gateway Investment Advisers LLC (0.13%), PGGM Investments (0.06%), State of Alaska Department of Revenue (0.06%) and McGuire Investment Group LLC (0.03%). Company insiders that own Hologic stock include Allison P Bebo, Benjamin Jordan Cohn, Charles J Dockendorff, Christiana Stamoulis, John M Griffin, Karleen Marie Oberton, Namal Nawana, Peter J Valenti III, Sally Crawford and Stephen P Macmillan. View Institutional Ownership Trends for Hologic.

HOLX stock was sold by a variety of institutional investors in the last quarter, including Meag Munich Ergo Kapitalanlagegesellschaft MBH, State of Alaska Department of Revenue, Gateway Investment Advisers LLC, Nisa Investment Advisors LLC, McGuire Investment Group LLC, Webster Bank N. A., IFM Investors Pty Ltd and Raymond James Trust N.A.. Company insiders that have sold Hologic company stock in the last year include Benjamin Jordan Cohn, Christiana Stamoulis, John M Griffin, Karleen Marie Oberton, Peter J Valenti III, Sally Crawford and Stephen P Macmillan. View Insider Buying and Selling for Hologic.

HOLX stock was bought by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., PGGM Investments, Wedge Capital Management L L P NC, Sciencast Management LP, Zeke Capital Advisors LLC, AE Wealth Management LLC and Cerebellum GP LLC. Company insiders that have bought Hologic stock in the last two years include Charles J Dockendorff and Namal Nawana. View Insider Buying and Selling for Hologic.

Shares of HOLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of HOLX stock can currently be purchased for approximately $54.32.

Hologic has a market capitalization of $14.57 billion and generates $3.37 billion in revenue each year. The medical equipment provider earns $-203,600,000.00 in net income (profit) each year or $2.43 on an earnings per share basis. Hologic employs 6,478 workers across the globe.View Additional Information About Hologic.

The official website for Hologic is http://www.hologic.com/.

Hologic's mailing address is 250 CAMPUS DRIVE, MARLBOROUGH MA, 01752. The medical equipment provider can be reached via phone at 508-263-2900 or via email at [email protected]